The impact of HF-rTMS treatment on serotonin2A receptors in unipolar melancholic depression

Brain Stimulation

Volumn 4, Issue 2, 2011, Pages 104-111

  Baeken, Chris ^a   De Raedt, Rudi ^b   Bossuyt, Axel ^a   Van Hove, Christian ^a   Mertens, John ^c   Dobbeleir, André ^d   Blanckaert, Peter ^b   Goethals, Ingeborg ^d  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

5 HT2A receptor; HF rTMS; major depression; melancholia; serotonin; SPECT; treatment resistance

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; BROMAZEPAM; CLOMIPRAMINE; CLONAZEPAM; DOSULEPIN; DULOXETINE; FLUNITRAZEPAM; FLURAZEPAM; LORAZEPAM; LORMETAZEPAM; NORTRIPTYLINE; PAROXETINE; PHENELZINE; SEROTONIN 2A RECEPTOR; TRAZODONE; VENLAFAXINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; MAJOR DEPRESSION; MALE; NEUROBIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; RECEPTOR BINDING; REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION; SEROTONINERGIC SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TRANSCRANIAL MAGNETIC STIMULATION;

ADULT; ANIMALS; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; RECEPTOR, SEROTONIN, 5-HT2A; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TRANSCRANIAL MAGNETIC STIMULATION;

ANIMALIA;

EID: 79955077713     PISSN: 1935861X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brs.2010.09.002     Document Type: Article

References (59)

1. M. Wong, and J. Licinio Research and treatment approaches to depression Nat Rev Neurosci 2 2001 343 352
2. M. Fava The role of the serotonergic and noradrenergic neurotransmitter systems in the treatment of psychological and physical symptoms of depression J Clin Psychiatry 64 Suppl 13 2003 26 29 (Pubitemid 37267812)
3. A. Neumeister, and D.S. Charney Monoaminergic transmitter systems H.A.H. D'haenen, J.A. den Boer, P. Willner, Biological Psychiatry 2002 John Wiley & Sons Ltd Chichester, UK 727 738
4. M.S. George, Z. Nahas, and X. Li Novel treatments of mood disorders based on brain circuitry (ECT, MST, TMS, VNS, DBS) Semi Clin Neuropsychiatry 7 2002 293 304
5. J.P. O'Reardon, H.B. Solvason, and P.G. Janicak Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial Biol Psychiatry 62 2007 1208 1216 (Pubitemid 350060890)
6. M.S. George, Z. Nahas, and F. Kozol Mechanisms and the current state of transcranial magnetic stimulation CNS Spectr 8 2003 496 514
7. A. Post, and M.E. Keck Transcranial magnetic stimulation as a therapeutic tool in psychiatry: what do we know about the neurobiological mechanisms? J Psychiatry Res 35 2001 193 215 (Pubitemid 32913028)
8. T. Yukimasa, R. Yoshimura, and A. Tamagawa High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors Pharmacopsychiatry 39 2006 52 59
9. R. Zanardini, A. Gazzoli, and M. Ventriglia Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients J Affect Disord 91 2006 83 86 (Pubitemid 43254643)
10. P.B. Fitzgerald, T.J. Oxley, and A.R. Laird An analysis of functional neuroimaging studies of dorsolateral prefrontal cortical activity in depression Psychiatry Res 148 2006 33 45 (Pubitemid 44679820)
11. D. Ben-Shachar, H. Gazawi, and J. Riboyad-Levin Chronic repetitive transcranial magnetic stimulation alters beta-adrenergic and 5-HT2 receptor characteristics in rat brain Brain Res 816 1999 78 83 (Pubitemid 29225425)
12. I. Sibon, A.P. Strafella, and P. Gravel Acute prefrontal cortex TMS in healthy volunteers: effects on brain 11C-alphaMtrp trapping Neuroimage 34 2007 1658 1664 (Pubitemid 46187059)
13. J.F. López-Giménez, G. Mengod, and J.M. Palacios Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL100,907 Naunyn-Schmiedeberg's Arch Pharmacol 356 1997 446 454 (Pubitemid 27402083)
14. N.M. Barnes, and T. Sharp A review of central 5-HT receptors and their function Neuropharmacology 38 1999 1083 1152 (Pubitemid 29292403)
15. R. Hinz, Z. Bhagwagar, and P.J. Cowen Validation of a tracer kinetic model for the quantification of 5-HT2A receptors in human brain with [11C]MDL 100,907 J Cerebral Blood Flow Metabolism 27 2007 161 172 (Pubitemid 46006594)
16. V.A. Vaidya, G.J. Marek, and G.K. Aghajanian 5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex J Neurosci 17 1997 2785 2795 (Pubitemid 27155012)
17. 2 receptor changes in major depression Biol Psychiatry 27 1990 489 496 (Pubitemid 20091992)
18. J.J. Mann Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior Neuropsychopharmacol 21 1999 99S 105S (Pubitemid 29396477)
19. H. D'haenen Imaging the serotonergic system in depression Eur Arch Psychiatry Clin Neurosci 251 S2 2001 II/76 II/80
20. K. Audenaert, K. Van Laere, and F. Dumont Decreased frontal serotonin 5-HT 2a receptor binding index in deliberate self-harm patients Eur J Nucl Med 28 2001 175 182
21. H. D'haenen Radioligand studies in depression A. Otte, K. Audenaert, K. Peremans, K. Van Heeringen, R.A. Dierckx, Nuclear medicine in psychiatry 2004 Springer-Verlag Berlin 350 357
22. D. Terriere, P.M.F. Janssen, and W. Gommeren Evaluation of radioiodo-4-amino-N-[1-[3-(4-fluorophenoxy)-propyl]-4-methyl-4-piperidinyl] -5-iodo-2-methoxybenzamide as a potential 5-HT2 receptor tracer for SPE(C)T Nucl Med Biol 22 1995 1005 1010
23. C.C. Meltzer, G. Smith, and J.C. Price Reduced binding of [18F]altanserin to serotonin type 2A receptors in aging: persistence of effect after partial volume correction Brain Res 813 1998 167 171 (Pubitemid 29012530)
24. 18F]altanserin positron emission tomography Biol Psychiatry 55 2004 217 224 (Pubitemid 38117157)
25. K.H. Adams, H. Pinborg, and C. Svarer A database of [(18) F]-altanserin binding to 5-HT (2A) receptors in normal volunteers: normative data and relationship to physiological and demographic variables Neuroimage 21 2004 1105 1113 (Pubitemid 38314973)
26. P. Celada, M. Puig, and M. Amargos-Bosch The therapeutic role of 5-HT1A and 5-HT2A receptors in depression J Psychiatry Neurosci 29 2004 252 265 (Pubitemid 39185866)
27. J.G. Hensler Serotonergic modulation of the limbic system Neurosci Biobehav Rev 30 2006 203 214 (Pubitemid 41821809)
28. P.W. Burnet, T. Sharp, and S.M. LeCorre Expression of 5-HT receptors and the 5-HT transporter in rat brain after electroconvulsive shock Neurosci Lett 277 1999 79 82
29. R. Zanardi, F. Artigas, and R. Moresco Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: a positron emission tomography scan study J Clin Psychopharmacol 21 2001 53 58 (Pubitemid 32096750)
30. D.V. Sheehan, Y. Lecrubier, and K.H. Sheehan The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 J Clin Psychiatry 59 1998 22 33 (Pubitemid 29001829)
31. M.E. Thase, and A. Rush When at first you don't succeed: sequential strategies for antidepressant nonresponders J Clin Psychiatry 58 Suppl 13 1997 23 29 (Pubitemid 28011969)
32. M. Hamilton Development of a rating scale for primary depressive illness Br J Social Clin Psychology 6 1967 278 296
33. K. Peleman, P. Van Schuerbeek, and R. Luypaert Using 3D-MRI to localize the dorsolateral prefrontal cortex in TMS research World J Biol Psychiatry 11 Pt 2 2010 425 430
34. S. Rossi, M. Hallett, P.M. Rossini, and A. Pascual-Leone Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research Clin Neurophysiol 120 2009 2008 2039
35. 2A receptor binding in patients with anorexia nervosa J Nucl Med 44 2003 163 169
36. I. Goethals, M. Vervaet, and K. Audenaert Comparison of cortical 5-HT2A receptor binding in bulimia nervosa patients and healthy volunteers Am J Psychiatry 161 2004 1916 1918 (Pubitemid 39314690)
37. 2A ligand for single-photon emission tomography, in healthy human subjects Eur J Nucl Med 24 1997 119 124 (Pubitemid 27121089)
38. C. Baeken, H. D'haenen, and P. Flamen 123I-5-I-R91150, a new single-photon emission tomography ligand for 5-HT2A receptors: influence of age and gender in healthy subjects Eur J Nucl Med 25 1998 1617 1622 (Pubitemid 29008343)
39. A.M. Catafau, M. Danus, and S. Bullich Characterization of the SPECT 5-HT2A receptor ligand 123I-R91150 in healthy volunteers: part 1 - pseudoequilibrium interval and quantification methods J Nucl Med 47 2006 919 928 (Pubitemid 46939943)
40. F. Biver, D. Wikler, and F. Lotstra Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex Br J Psychiatry 171 1997 444 448 (Pubitemid 27475842)
41. D. Van Oekelen, W.H.M.L. Luyten, and J.E. Leysen 5-HT2A and 5-HT2C receptors and their atypical regulation properties Life Sci 72 2003 2429 2449 (Pubitemid 36321816)
42. Z. Bhagwagar, R. Hinz, and M. Taylor Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [(11)C]MDL 100,907 Am J Psychiatry 163 2006 1580-1507
43. C.C. Meltzer, J.C. Price, and C.A. Mathis PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders Am J Psychiatry 156 1999 1871 1878
44. R.J. Porter, and P. Gallagher Abnormalities of the HPA axis in affective disorders: clinical subtypes and potential treatments Acta Neuropsychiatrica 18 2006 193 209 (Pubitemid 44655303)
45. H.D. Schmidt, and R.S. Duman The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior Behav Pharmacol 18 2007 391 418 (Pubitemid 47356367)
46. M. Amano, K. Suemaru, and R. Cui Effects of physical and psychological stress on 5-HT2A receptor-mediated wet-dog shake responses in streptozotocin-induced diabetic rats Acta Med Okayama 61 2007 205 212 (Pubitemid 47502133)
47. W.C. Drevets, W. Bogers, and M.E. Raichle Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism Eur Neuropsychopharmacol 12 2002 527 544 (Pubitemid 35408704)
48. Y. Levkovitz, and M. Segal Aging affects transcranial magnetic modulation of hippocampal evoked potentials Neurobiol Aging 22 2001 255 263 (Pubitemid 32162974)
49. Y. Levkovitz, N. Grisaru, and M. Segal Transcranial magnetic stimulation and antidepressive drugs share similar cellular effects in rat hippocampus Neuropsychopharmacol 24 2001 608 616 (Pubitemid 32452208)
50. K. Martinowich, and B. Lu Interaction between BDNF and serotonin: role in mood disorders Neuropsychopharmacol 33 2008 73 83 (Pubitemid 350191318)
51. V.A. Vaidya, R.M. Terwilliger, and R.S. Duman Role of 5-HT2A receptors in the stress-induced down-regulation of brain-derived neurotrophic factor expression in rat hippocampus Neurosci Lett 262 1999 1 4 (Pubitemid 29104944)
52. C.A. Lowry Functional subsets of serotonergic neurones: implications for control of the hypothalamic-pituitary-adrenal axis J Neuroendocrinol 14 2002 911 923 (Pubitemid 35378709)
53. M.B. Müller, N. Toschi, and A.E. Kresse Long-term repetitive transcranial magnetic stimulation increases the expression of brain-derived neurotrophic factor and cholecystokinin mRNA, but not neuropeptide tyrosine mRNA in specific areas of rat brain Neuropsychopharmacol 23 2000 205 215 (Pubitemid 30406905)
54. E. Dremencov, E. Gur, and B. Lerer Effects of chronic antidepressants and electroconvulsive shock on serotonergic neurotransmission in the rat hippocampus Prog Neuropsychopharmacol Biol Psychiatry 27 2003 729 739 (Pubitemid 36966753)
55. A.R. Brunoni, M. Lopes, and T.J. Kaptchuk Placebo response of non-pharmacological and pharmacological trials in major depression: a systematic review and meta-analysis PLoS One 4 2009 e4824
56. A.M. Leventhal, and L.P. Rehm The empirical status of melancholia: implications for psychology Clin Psychol Rev 25 2005 25 44 (Pubitemid 41556532)
57. A.A. Gershon, P.N. Dannon, and L. Grunhaus Transcranial magnetic stimulation in the treatment of depression Am J Psychiatry 160 2003 835 845 (Pubitemid 41079567)
58. D.J. Schutter Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis Psychol Med 39 2009 65 75
59. O. Pogarell, W. Koch, and G. Pöpperl Striatal dopamine release after prefrontal repetitive transcranial magnetic stimulation in major depression: preliminary results of a dynamic [123I] IBZM SPECT study J Psychiatr Res 40 2006 307 314 (Pubitemid 43668986)